Warning letter
PI Pharma Inc: warning letter of Oct 30, 2014
FDA warning letter 422732 · Cincinnati District Office
Key facts
| Reference number | 422732 |
|---|---|
| Company | PI Pharma Inc |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Oct 30, 2014 |
| Posted date | Oct 30, 2014 |
| Issuing office | Cincinnati District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.70(e), 111, 111.73, 111.70(b), 111.70(f), 111.255(b), 111.260(b), 111.260(c), 111.260(k), 111.260(k)(1), 111.260(k)(3), 111.260(l)(4) and 10 more |
| Inspection city | Campton |
| Inspection ZIP | 41301 |
| Inspection start date | Feb 10, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: